InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,266.95
(
-0.74%
)
US TECH 100
18,178.40
(
-1.14%
)
Dow Jones
38,441.54
(
-1.06%
)
Brent Oil
83.43
(
0.06%
)
Bitcoin
68,084.13
(
0.74%
)
Post# of 460101
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

bas2020

Send PM Follow Ignore
Followers 66
Posts 12700
Boards Moderated 0
Alias Born 06/03/2015

bas2020

Re: JB3729 post# 66802

Sunday, 07/03/2016 3:41:09 PM

Sunday, July 03, 2016 3:41:09 PM

Post# of 460101
75% of P2a trial patients were taking donepezil and 25% were not. That's how the company determined that the combo drug might not be additively beneficial than 2-73 alone.

It's anticipated that the P3 trial will be double-blinded: 2-73 vs. donepezil (not placebo, since the FDA already has reams of placebo data from previous trials).
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM

One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM

Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM

HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!